Tellgen Corporation (SHE:300642)

China flag China · Delayed Price · Currency is CNY
17.95
+0.43 (2.45%)
Mar 10, 2026, 3:04 PM CST
18.25%
Market Cap 2.80B
Revenue (ttm) 373.48M
Net Income (ttm) 15.92M
Shares Out 159.86M
EPS (ttm) 0.10
PE Ratio 178.40
Forward PE n/a
Dividend 0.15 (0.86%)
Ex-Dividend Date May 20, 2025
Volume 2,373,160
Average Volume 2,912,905
Open 17.25
Previous Close 17.52
Day's Range 17.25 - 17.97
52-Week Range 11.51 - 32.80
Beta 0.44
RSI 39.35
Earnings Date Apr 25, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 522
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300642
Full Company Profile

Financial Performance

In 2024, Tellgen's revenue was 436.78 million, a decrease of -19.53% compared to the previous year's 542.81 million. Earnings were 34.53 million, a decrease of -61.37%.

Financial Statements

News

There is no news available yet.